Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressures

Journal of Clinical Epidemiology

Volumn 59, Issue 7, 2006, Pages 739-746

  Piette, John D ^a   Heisler, Michele ^a   Wagner, Todd H ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Adherence; Chronic disease; Health care costs; Self care

Indexed keywords

ADULT; AGED; AGING; ARTHRITIS; ARTICLE; ASTHMA; BACKACHE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DECISION MAKING; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DRUG COST; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH SURVEY; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEARTBURN; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OSTEOPOROSIS; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; SELF CARE; SOCIAL ASPECT; STOMACH ULCER; STROKE; SYMPTOM; UNITED STATES;

AGED; ANALGESICS; CHOICE BEHAVIOR; CHRONIC DISEASE; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PRESCRIPTION FEES; REGRESSION ANALYSIS; SELF MEDICATION; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 33744740349     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2005.11.023     Document Type: Article

References (35)

1. Safran D.G., Neuman P., Schoen C., et al. Prescription drug coverage and seniors: how well are states closing the gap?. Health Aff(Millwood) (2002) W253-W268
2. Steinman M.A., Sands L.P., and Covinsky K.E. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 16 (2001) 793-799
3. Tamblyn R., Laprise R., Hanley J.A., et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 285 (2001) 421-429
4. Soumerai S.B., Ross-Degnan D., Avorn J., McLaughlin T.J., and Choodnovsky I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 325 (1991) 1072-1077
5. Heisler M., Langa K., Eby E.L., Fendrick A.M., Kabeto M.U., and Piette J.D. The health effects of restricting prescription medication use because of cost. Med Care 42 (2004) 626-634
6. Ess S.M., Schneeweiss S., and Szucs T.D. European healthcare policies for controlling drug expenditures. Pharmacoeconomics 21 (2003) 89-103
7. Danzon P.M., and Furukawa M.F. Prices and availability of pharmaceuticals: evidence from nine countries. Health Aff (Millwood) (2004) W3-521-36
8. Noyce P.R., Hutten C., Atella V., Brenner G., Haaijer-Ruskamp F.M., and Hedvall M.B. The cost of prescription medicines to patients. Health Policy 52 (2000) 129-145
9. Krobot K.J., Miller W.C., Kaufman J.S., Christensen D.B., Preisser J.S., and Ibrahim M.A. The disparity in access to new medication by type of health insurance: lessons from Germany. Med Care 42 (2004) 487-491
10. Hagihara A.M., Murakami M., Chishaki A., Nabeshima F., and Nobutomo K. Rate of health insurance reimbursement and adherence to anti-hypertensive treatment among Japanese patients. Health Policy 58 (2001) 231-242
11. Pourat N., Rice T., Kominski G., and Snyder R.E. Socioeconomic differences in Medicare supplemental coverage. Health Aff (Millwood) 19 (2000) 186-196
12. Fortess E.E., Soumerai S.B., McLaughlin T.J., and Ross-Degnan D. Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting. J Am Geriatr Soc 49 (2001) 793-797
13. Goldman D., Joyce G.F., Escarce J.J., et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA 291 (2004) 2344-2350
14. Harris B.L., Stergachis A., and Reid D. The effect of drug co-payment on utilization and cost of pharmaceuticals in a health maintenance organization. Med Care 28 (1990) 907-917
15. Toner R, Stolberg S. Decade after health care crisis: soaring costs bring new strains. New York Times August 11, 2002. p. 1.
16. Ortendahl M., and Fries J.F. Time-related issues with application to health gains and losses. J Clin Epidemiol 55 (2002) 843-848
17. National Health and Nutrition Examination Survey: patters of prescription drug use in the United States, 1988-94. Accessed June 12, 2003. Web Page. Available at: http://www.cdc.gov/nchs/data/nhanes/databriefs/preuse.pdf.
18. Piette J.D., Heisler M., and Wagner T.H. Cost-related medication under-use among chronically-ill adults: the treatments people forego, how often, and who is at risk. Am J Public Health 94 (2004) 1782-1787
19. Krosnick J.A., and Chang L. A comparison of random digit dialing telephone survey methodology with internet survey methodology as implemented by Knowledge Networks and Harris Interactive (2001), Ohio State University. http://www.knowledgenetworks.com/ganp/reviewer-info.html Available at:
20. Wagner TH. Using the internet to conduct surveys with veterans: Knowledge Network's sample and sampling validity. accessed June 2, 2003. Web Page. Available at: http://www.herc.research.med.va.gov/wagner_CHI.htm.
21. Soumerai S.B., Avorn J., Ross-Degnan D., and Gortmaker S. Payment restrictions for prescription drugs under Medicaid: effects on therapy, cost, and equity. N Engl J Med 317 (1987) 550-556
22. Stata Corporation. Release 8.1. [Stata Statistical Software] (2003), Stata Corporation, College Station, TX
23. Tomz M, Wittenberg J, King G. Stanford University, University of Wisconsin, and Harvard University; 2003. Available at: http://gking.harvard.edu/.
24. King G., Tomz M., and Wittenberg J. Making the most of statistical analysis: improving interpretation and presentation. Am J Polit Sci 44 (2000) 347-361
25. Goldman D.P., Joyce G.F., Escarce J.J., et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA 291 (2004) 2344-2350
26. Druss B.G., Rosenheck R.A., and Sledge W.H. Health and disability costs of depressive illness in a major U.S. corporation. Am J Psychiatry 157 (2000) 1274-1278
27. Schoenbaum M., Unutzer J., Sherbourne C., et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA 286 (2001) 1325-1330
28. Burton W.N., Conti D.J., Chen C.Y., Schultz A.B., and Edington D.W. The economic burden of lost productivity due to migraine headache: a specific worksite analysis. J Occup Environ Med 44 (2002) 523-529
29. Rizzo J.A., Abbot III T.A., and Berger M.L. The labor productivity effects of chronic backache in the United States. Med Care 36 (1998) 1471-1488
30. DiMatteo M.R. Patient adherence to pharmacotherapy: the importance of effective communication. Formulary 30 (1995) 596-598 601-2, 605
31. Bultman D.C., and Svarstad B.L. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns 40 (2000) 173-185
32. Alexander G.C., Casalino L.P., and Meltzer D.O. Patient-physician communication about out-of-pocket costs. JAMA 290 (2003) 953-958
33. Piette J.D., Heisler M., and Wagner T.H. Cost-related medication under-use: do patients with chronic illnesses tell their doctors?. Arch Intern Med 164 (2004) 1749-1755
34. Heisler M.E., Wagner T.H., and Piette J.D. Clinician identification of patients with chronic illnesses who face problems paying for prescription medications. Am J Med 116 (2004) 753-758
35. Piette J.D., Heisler M., Horne R., and Alexander G. A conceptually-based approach to understanding chronically-ill patients' responses to medication cost pressures. Soc Sci Med (2005) Epub ahead of print